DE PETRO, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 9.648
EU - Europa 6.493
AS - Asia 5.991
SA - Sud America 1.113
Continente sconosciuto - Info sul continente non disponibili 379
AF - Africa 126
OC - Oceania 25
AN - Antartide 1
Totale 23.776
Nazione #
US - Stati Uniti d'America 9.385
CN - Cina 2.053
SG - Singapore 1.959
PL - Polonia 1.494
DE - Germania 1.159
UA - Ucraina 953
BR - Brasile 912
IT - Italia 884
HK - Hong Kong 516
FR - Francia 434
FI - Finlandia 428
VN - Vietnam 403
GB - Regno Unito 335
IN - India 307
RU - Federazione Russa 275
TR - Turchia 205
BD - Bangladesh 164
IE - Irlanda 158
CA - Canada 141
SE - Svezia 105
ID - Indonesia 77
AR - Argentina 74
MX - Messico 66
BE - Belgio 53
NL - Olanda 47
JP - Giappone 43
IQ - Iraq 42
ZA - Sudafrica 40
EC - Ecuador 38
AT - Austria 34
ES - Italia 34
PK - Pakistan 29
CO - Colombia 24
AU - Australia 23
RO - Romania 22
EU - Europa 21
SA - Arabia Saudita 21
KR - Corea 18
JM - Giamaica 17
PY - Paraguay 17
JO - Giordania 15
KE - Kenya 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
MA - Marocco 14
UZ - Uzbekistan 14
VE - Venezuela 14
CH - Svizzera 13
CL - Cile 12
CR - Costa Rica 11
CZ - Repubblica Ceca 11
LT - Lituania 11
NG - Nigeria 11
OM - Oman 10
AZ - Azerbaigian 9
TH - Thailandia 9
IL - Israele 8
MY - Malesia 8
BO - Bolivia 7
EG - Egitto 7
KZ - Kazakistan 7
MU - Mauritius 7
PE - Perù 7
SD - Sudan 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
DZ - Algeria 6
PH - Filippine 6
RS - Serbia 6
HN - Honduras 5
LY - Libia 5
TW - Taiwan 5
BH - Bahrain 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
DM - Dominica 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RE - Reunion 2
Totale 23.390
Città #
Warsaw 1.488
Singapore 1.050
Ashburn 732
Jacksonville 676
Fairfield 605
Hong Kong 505
Woodbridge 469
San Jose 467
Chandler 465
Beijing 436
Ann Arbor 391
The Dalles 360
Houston 324
Wilmington 295
Princeton 288
New York 278
Council Bluffs 267
Nanjing 266
Cambridge 263
Helsinki 256
Seattle 239
Brescia 237
Los Angeles 220
Lauterbourg 161
Dublin 157
Columbus 151
Dearborn 151
Istanbul 149
Ho Chi Minh City 134
Buffalo 119
Des Moines 110
Munich 107
Chicago 104
Dallas 101
Milan 91
Nanchang 91
São Paulo 80
Moscow 76
Shenyang 72
Orem 71
Dong Ket 70
Jinan 68
Hebei 67
Santa Clara 66
Shanghai 65
Changsha 63
San Francisco 63
Redondo Beach 52
Tianjin 52
Hanoi 50
Brussels 49
Jiaxing 49
Lancaster 48
Jakarta 47
Kunming 41
Toronto 39
Pune 35
Turku 35
Brooklyn 34
Rio de Janeiro 34
Tokyo 34
Phoenix 32
San Diego 32
Chennai 30
Guangzhou 30
Atlanta 28
Hangzhou 28
London 28
Mexico City 28
Montreal 28
Lappeenranta 27
Verona 27
Salt Lake City 26
Zhengzhou 26
Johannesburg 25
Kocaeli 25
Mumbai 25
Rome 25
Amsterdam 24
Boardman 24
Frankfurt am Main 24
Nuremberg 23
Charlotte 22
Denver 20
North York 19
Ningbo 18
Manchester 17
Nürnberg 17
Boston 16
Philadelphia 16
Tampa 16
Vienna 16
Baghdad 15
Belo Horizonte 15
Curitiba 15
Da Nang 15
Stockholm 15
Amman 14
Bari 14
Brasília 14
Totale 14.422
Nome #
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 358
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 355
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 324
Environment and bladder cancer: molecular analysis by interaction networks 320
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 294
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 276
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 267
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 262
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 256
Transmembrane protein TMEM230, regulator of metalloproteins and motor proteins in gliomas and gliosis 243
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 237
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 233
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 230
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 227
Functional Role of microRNA-23b-3p in Cancer Biology 224
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 224
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 220
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 212
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 210
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 208
Biological Function of MicroRNA193a-3p in Health and Disease 207
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 196
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 192
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 192
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 190
Preparazione di colture primarie di fibroblasti di embrione di pollo . 187
microRNAs and human hepatocellular carcinoma 184
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 184
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 183
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 180
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 176
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 174
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 173
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 170
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 170
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 167
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 167
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 163
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 161
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 157
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 155
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 154
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 153
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 153
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 153
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 152
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 151
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 150
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 150
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 144
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 142
Transformation-enhancing activity of gelatin binding fragments of fibronectin 141
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 141
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 139
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 139
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 139
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 139
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 138
Urokinase and c-met are target of miR-23b in human cells. 137
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 137
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 137
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 137
DNA methylation variations in familial female and male breast cancer 137
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 136
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 135
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 134
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 133
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 132
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 131
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 131
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 130
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 130
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 129
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 129
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 128
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 128
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 128
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 126
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 126
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 126
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 126
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 123
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 122
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 122
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 122
La trascrizione in Molecole, cellule e Organismi 122
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 121
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 120
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 119
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 119
Conditional interactions of fibronectin: C-reactive protein, sulfated proteoglycans, and malignant transformation. 118
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 118
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 117
Role of fibronectin degradation products on cellular transformation. 117
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 116
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 116
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 116
Tecniche di conservazione delle cellule mediante congelamento. 115
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 115
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 114
Totale 16.661
Categoria #
all - tutte 102.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022909 0 0 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/20253.527 41 64 66 462 326 306 283 119 442 186 802 430
2025/20266.452 600 850 477 935 626 518 880 255 394 557 248 112
2026/2027896 296 291 309 0 0 0 0 0 0 0 0 0
Totale 23.776